Vapogenix Lands $5,100,000 Series B Financing

  • Feed Type
  • Date
    3/10/2015
  • Company Name
    Vapogenix
  • Mailing Address
    8285 El Rio St. Houston, TX 77054 USA
  • Company Description
    Vapogenix is a clinical stage company developing a new class of non-narcotic analgesics for localized pain. While most pain is localized, most pain medications are administered orally (systemically), resulting in side effects.
  • Website
    http://www.vapogenix.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,100,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The company intends to use the funds to advance the aforementioned programs.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy